AChR Alpha9 Polyclonal Antibody

CHRNA9 (cholinergic receptor nicotinic alpha 9 subunit) is a member of the ligand-gated ionic channel family and nicotinic acetylcholine receptor gene superfamily. It encodes a plasma membrane protein that forms homo- or hetero-oligomeric divalent cation channels. This protein is involved in cochlea hair cell development and is also expressed in the outer hair cells (OHCs) of the adult cochlea.

The ACHR ALPHA9 Polyclonal Antibody is a highly specialized and meticulously developed product that serves as an invaluable tool in the field of biomedical research. This antibody is specifically designed to target and detect the alpha9 subunit of the acetylcholine receptor (ACHR), a crucial component in the transmission of nerve impulses.

Crafted with utmost precision and utilizing cutting-edge technology, this polyclonal antibody exhibits exceptional sensitivity and specificity, ensuring accurate and reliable results. Its superior affinity for the alpha9 subunit enables precise identification and localization of this critical receptor in various biological samples.

The ACHR ALPHA9 Polyclonal Antibody is meticulously validated through rigorous quality control measures, guaranteeing its exceptional performance and reproducibility. Its outstanding performance is further enhanced by its compatibility with a wide range of experimental techniques, including immunohistochemistry, immunofluorescence, and Western blotting.

Researchers and scientists can confidently rely on this antibody to unravel the intricate mechanisms underlying the function and regulation of the alpha9 subunit of the acetylcholine receptor. Its application extends to diverse areas of study, including neuroscience, pharmacology, and developmental biology.

With its unparalleled specificity, sensitivity, and versatility, the ACHR ALPHA9 Polyclonal Antibody is an indispensable asset for any laboratory or research institution seeking to advance their understanding of the acetylcholine receptor and its associated pathways.